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Risk of leukemia in first degree 
relatives of patients with 
nonsyndromic cleft lip and palate
Abstract: The aim of this study was to determine the frequency of 
leukemia in parents of patients with nonsyndromic cleft lip and/or 
cleft palate (NSCL/P). This case-control study evaluated first-de-
gree family members of 358 patients with NSCL/P and 1,432 sub-
jects without craniofacial alterations or syndromes. Statistical 
analysis was carried out using Fisher’s test. From the 358 subjects 
with NSCL/P, 3 first-degree parents had history of leukemia, while 
2 out of 1,432 subjects from the unaffected group had a family his-
tory of leukemia. The frequency of positive family history of leu-
kemia was not significantly increased in first-degree relatives of 
patients with NSCL/P.
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Introduction
Cancer and birth defects may share factors that influence risk, being 
of genetic and/or environmental origin.1 Furthermore, a malformation 
may involve physiological changes or changes in lifestyle that might 
in turn affect cancer risk.2 Nonsyndromic cleft lip and/or cleft palate 
(NSCL/P, OMIM #119530) is the most common craniofacial birth defect 
in humans, with a global prevalence ranging from 1:500 to 1:2,500 live 
births,3 depending on ancestry, geographic residential location, maternal 
age and prenatal exposures, and socioeconomic status.4
In recent years, epidemiological evidence has shown the association 
of cancer with NSCL/P in several populational studies.5,6,7,8 It has been 
proposed that cancer and congenital malformations such as NSCL/P may 
occasionally have a common etiology. The underlying concept is that the 
same genes can act in normal and also malignant development.1,7 The 
association between NSCL/P and leukemia remains unclear and there 
are no studies evaluating this association in Brazil.
The aim of the current study was to determine the frequency of 
leukemia in parents of subjects with NSCL/P in a Brazilian population.
Methodology
After proper local and Center for Rehabilitation of Craniofacial 
Anomalies, Minas Gerais State, Brazil, Institutional Review Board 
approval, we conducted a case-control study which was approved 
by the Ethics Committee on Institutional Research #259/2009, for the 
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time period of 2010-2012, evaluating 358 patients 
with NSCL/P, seen at a referral center for the 
treatment of craniofacial deformities, and 1,432 
patients without craniofacial alterations or any 
syndrome (control group), identified randomly 
from the General Clinics of the Dental School at the 
Universidade de Alfenas, Minas Gerais State, Brazil. 
We obtained information concerning the gender, 
age and family history of leukemia in first-degree 
relatives (mother, father and siblings) for both 
groups. No participants declined to respond to 
the questionnaire. The t-test assessed whether the 
means of age for the two groups were statistically 
different from each other. Statistical analyses were 
also carried out using Fisher’s exact test (expected 
frequency values fell below 5) and the odds ratio 
(OR) with its 95% confidence interval (95%CI) to 
estimate the magnitude of the risk. Values with 
p < 0.05 were considered statistically significant.
Results
The average age of the cases diagnosed with NSCL/P 
was 13.57 years. The average age of the control group was 
14.22 years. There was no difference of age distribution 
between affected and unaffected women (p = 0.55). From 
the 358 subjects with NSCL/P, 3 first-degree relatives 
had a positive family history of leukemia, while 2 of the 
1,432 subjects from the unaffected group had a positive 
family history of leukemia (Table 1). The Fisher exact test 
showed p = 0.057 and OR = 6.04 (95%CI = 0.69 - 72.49). 
Thus, in the present study the frequency of leukemia 
was not significantly increased in the first-degree 
relatives of patients with NSCL/P.
Discussion
In the present study the frequency of positive 
family history of leukemia was not significantly 
increased in first-degree relatives of patients with 
NSCL/P. Similarly, the risk of breast cancer in families 
with patients affected by NSCL/P was not increased.9 
On the other hand, a study showed a family history of 
cancer (colon, brain, leukemia, breast, prostate, skin, 
lung and liver) more often in relatives of NSCL/P 
compared to the control group. Recently, we evaluated 
the risk of NSCL/P in relatives of women with breast 
cancer in the Brazilian population and found no 
association between the two conditions.5,10
Another study11 showed that among cancer 
survivors with a family member with NSCL/P, 
there was an apparent excess of testicular cancer 
and melanoma in comparison with the cancer 
survivors with no family history of NSCL/P. These 
preliminary results suggest a common etiologic 
background for cancer and NSCL/P.
A recent study assessed the frequency of NSCL/P 
in families of children diagnosed with leukemia. 
The results of this study provide suggestive evidence 
that families with children diagnosed with leukemia 
report a family history of NSCL/P more often than 
families without cases of pediatric cancer.7
The association between cancer and NSCL/P could 
be attributable to both genetic factors and/or familial 
environmental factors that are both teratogenic and 
carcinogenic.9 Another possibility could be that 
having a cleft leads to social marginalization and 
changes in lifestyle that may be predisposed to an 
individual and their family to cancer (i.e. smoking, 
high alcohol use, etc.).12
Conclusion
To invest igate the relat ionship between 
malformations and malignancies is important, as 
it is speculated that they might have common causes. 
In the present study the frequency of a positive 
family history of leukemia was not significantly 
increased in first-degree relatives of patients 
with NSCL/P. The main limitation of our study 
was the sample size. Studies with larger samples 
and molecular analyses are needed for a better 
understanding between NSCL/P and leukemia.
Table 1. Risk of leukemia in first-degree relatives of patients with nonsyndromic cleft lip and palate (NSCL/P)
Groups No of subjects Positive history of leukemia OR (95%CI)/p value
Control 1,432 2 Reference
NSCL/P 358 3 6.04 (0.69-72.49)/0.057
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